Stifel Nicolaus Issues Pessimistic Forecast for Silicon Laboratories (NASDAQ:SLAB) Stock Price

Silicon Laboratories (NASDAQ:SLAB) had its target price lowered by analysts at Stifel Nicolaus from $160.00 to $135.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The firm presently has a “buy” rating on the semiconductor company’s stock. Stifel Nicolaus’ target price indicates a potential upside of 16.68% from the stock’s previous close.

A number of other brokerages also recently issued reports on SLAB. StockNews.com raised shares of Silicon Laboratories to a “sell” rating in a research report on Wednesday, October 30th. Barclays cut their price target on shares of Silicon Laboratories from $120.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday. Needham & Company LLC reiterated a “buy” rating and set a $150.00 price objective on shares of Silicon Laboratories in a report on Thursday, July 25th. Finally, KeyCorp lowered their price objective on Silicon Laboratories from $150.00 to $115.00 and set an “overweight” rating for the company in a research report on Tuesday. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, Silicon Laboratories currently has an average rating of “Hold” and a consensus target price of $121.50.

Silicon Laboratories Stock Up 10.8 %

Silicon Laboratories stock opened at $115.70 on Tuesday. The firm has a market cap of $3.74 billion, a P/E ratio of -15.64 and a beta of 1.20. The business has a fifty day moving average of $112.29 and a two-hundred day moving average of $115.48. Silicon Laboratories has a twelve month low of $91.37 and a twelve month high of $154.91.

Silicon Laboratories (NASDAQ:SLAB) last issued its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.07. Silicon Laboratories had a negative return on equity of 12.40% and a negative net margin of 46.93%. The company had revenue of $166.00 million for the quarter, compared to the consensus estimate of $165.50 million. During the same quarter last year, the company earned $0.48 earnings per share. The firm’s revenue for the quarter was down 18.5% compared to the same quarter last year. Equities analysts expect that Silicon Laboratories will post -3.41 earnings per share for the current year.

Insiders Place Their Bets

In other news, SVP Brandon Tolany sold 845 shares of the stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $115.00, for a total value of $97,175.00. Following the transaction, the senior vice president now directly owns 43,615 shares of the company’s stock, valued at approximately $5,015,725. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.72% of the stock is currently owned by insiders.

Institutional Trading of Silicon Laboratories

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. BNP Paribas Financial Markets boosted its holdings in Silicon Laboratories by 5.9% in the first quarter. BNP Paribas Financial Markets now owns 44,997 shares of the semiconductor company’s stock valued at $6,467,000 after purchasing an additional 2,526 shares during the last quarter. Fidelis Capital Partners LLC purchased a new stake in shares of Silicon Laboratories in the first quarter worth about $55,000. Texas Permanent School Fund Corp grew its holdings in Silicon Laboratories by 2.8% during the first quarter. Texas Permanent School Fund Corp now owns 27,916 shares of the semiconductor company’s stock worth $4,012,000 after acquiring an additional 768 shares during the period. Envestnet Portfolio Solutions Inc. grew its holdings in Silicon Laboratories by 13.5% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 5,977 shares of the semiconductor company’s stock worth $859,000 after acquiring an additional 709 shares during the period. Finally, SG Americas Securities LLC raised its position in Silicon Laboratories by 88.9% during the first quarter. SG Americas Securities LLC now owns 1,840 shares of the semiconductor company’s stock valued at $264,000 after acquiring an additional 866 shares in the last quarter.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.